Published online Jul 28, 2022. doi: 10.3748/wjg.v28.i28.3747
Peer-review started: April 16, 2022
First decision: May 11, 2022
Revised: May 13, 2022
Accepted: June 22, 2022
Article in press: June 22, 2022
Published online: July 28, 2022
Processing time: 101 Days and 12.1 Hours
Anastomotic leakage (AL) has a wide range of clinical features ranging from radiological only findings to peritonitis and sepsis with multiorgan failure. An early diagnosis of AL is essential in order to establish the most appropriate treatment for this complication. Despite AL continues to be a dreadful compli-cation after colorectal surgery, there has been no consensus on its management. However, based on patient’s presentation and timing of the AL, there has been a gradual shift to a more conservative management, keeping surgery as the last option Reoperation for sepsis control is rarely necessary especially in those patients who already have a diverting stoma at the time of the leak. A nonoperative management is usually preferred in these patients. There are several treatment options, also for patients without a stoma who do not require a reoperation for a contained pelvic leak, including recently developed endoscopic procedures, such as clip placement or endoluminal vacuum-assisted therapy. More conservative treatments could be an option in patients who are clinically stable or in presence of a small defect.
Core Tip: The authors of the review have a remarkable clinical experience and scientific authority in colorectal surgery and related complications. The authors focus their attention on endoluminal vacuum therapy to treat anastomotic leakage in colorectal surgery. The authors highlight that most studies are heterogeneous in term of success rate definition, salvage and long-term results. Furthermore, there is paucity of comparative studies and thus definitive conclusions are not warranted at present time, as pointed out by the authors in their narrative review.